All Stories

Ionis chalks up phase 3 trial win as it works to grow the reach of Tryngolza

Already approved in a rare genetic disorder, Ionis' medicine demonstrated benefits in treating patients with moderate hypertriglyceridemia.

May 19, 2025 - 17:30
 0
Ionis chalks up phase 3 trial win as it works to grow the reach of Tryngolza
Already approved in a rare genetic disorder, Ionis' medicine demonstrated benefits in treating patients with moderate hypertriglyceridemia.
Read More

Tags:

Previous Article

Former President Joe Biden diagnosed with 'aggressive' prostate cancer

Next Article

AstraZeneca's Airsupra cuts risk of severe exacerbations by 47% in patients with...

Related Posts

Regulatory tracker: Travere's Filspari to face FDA adcomm in expansion bid

Regulatory tracker: Travere's Filspari to face FDA adco...

May 16, 2025  0

After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme

After 19 months, FDA lifts clinical hold on vaginal yea...

May 16, 2025  0

Trump signs sweeping executive order to cut US drug prices by 'up to 90%'

Trump signs sweeping executive order to cut US drug pri...

May 12, 2025  0